By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



38 the Fenway

Boston  Massachusetts  02215  U.S.A.
Phone: 617-536-0220 Fax: 617-536-0657



Company News
Replikins Release; New Genomic Analysis Shows H5N1 (Bird Flu) Replikin Count Highest Among Five Influenza Strains 10/10/2013 9:22:43 AM
Replikins Release: Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria 3/14/2013 10:19:51 AM
Replikins Release: Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count 2/20/2013 9:51:24 AM
New Shared Synthetic Replikins Cancer Vaccines 1/22/2013 10:12:12 AM
Replikins Release: Replikin Count of Influenza H3N2 Replikin Lethality Gene in the U.S. Approaches That of 1968 H3N2 Pandemic 1/17/2013 9:29:09 AM
Replikins Release: 2012 "State Fair" Swine Flu H3N2 Outbreak in U.S. was Correctly Predicted by Increase in Genomic Replikin®Count Two Years Earlier 11/30/2012 8:37:05 AM
Five New Cases of SARS-like Virus Bring Total to Seven, Prompting Calls for Immediate Trials of New Synthetic Replikins™Vaccine SARS2012 11/28/2012 8:25:35 AM
The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC 11/7/2012 9:22:00 AM
Replikins Release: Human SARS Virus Genomic Replikin™ Count Rises to the Level that Preceded the 2003 Lethal SARS Outbreak 10/8/2012 9:59:40 AM
Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikins Vaccines for Infectious Diseases and Cancer 6/20/2012 10:30:17 AM